MedTrace Logo

Neo-nervegenesis in Inguinal Hernia Implant ProFlor

NCT04171102 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2020-06-17

Study results available
· View outcomes & findings →

Summary

The investigation is aimed at specifically demonstrating the ingrowth of newly formed nervous elements within a 3D dynamic responsive implant for inguinal hernia repair.

Conditions

  • Inguinal Hernia

Interventions

DEVICE

ProFlor Hernia implant

Inguinal hernia repair

Sponsors & Collaborators

  • University of Cagliari

    lead OTHER

Principal Investigators

  • Giuseppe Amato, MD · University of Cagliari

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-12-31
Completion
2016-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04171102 on ClinicalTrials.gov